'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, Transocean, and DuPont. Here's the science behind the Los Angeles wildfires ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings ...

Mad Money' host Jim Cramer looks at several healthcare stocks and shares his perspective on their trajectory in 2025.

Jim Cramer is optimistic about top money-center bank stocks. These four look like outstanding ideas before their earnings ...

CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...

Shares of Palantir Technologies (NASDAQ: PLTR) advanced 1,110% during the last two years as the company benefited from strong ...

CNBC’s Jim Cramer extolled Nvidia’s stock and reviewed its Tuesday action, saying the decline was unrelated to the company ...

Netflix is the IBD Stock of the Day for Tuesday. Netflix stock rallied more than 80% last year, helped by accelerating sales ...

Cramer agreed with Goldman Sachs' Eric Sheridan, who suggested that Uber can produce mid-to-high teens growth in mobility ...

CNBC has started collecting signups for its standalone streaming service CNBC+. The service, which was ... Read More ...

CNBC will seek $14.99 a month, or $99.99 a year, for access to a new targeted streaming service called CNBC+ that executives ...